Alaska Administrative Code (Last Updated: January 12, 2017) |
Title 7. Health and Social Services. |
Part 7.1. Administration. |
Chapter 7.33. Methadone Programs. |
Section 7.33.075. Program rules and patient instructions.
Latest version.
-
(a) Each program shall develop a set of written rules and instructions which shall be provided to all patients receiving services and to applicants before the program accepts the applicant as a patient. Rules and instructions shall include, but are not limited to, urine collection requirements, fees, as well as clinic hours and provisions for emergencies. (b) Each program shall advise each patient of the nature and purpose of methadone, including hazards and risks involved in methadone treatment, of the patient's responsibility to the program and of the program's responsibility to the patient, that the patient's participation in the program is wholly voluntary, that he may terminate his participation in the program at any time without penalty, that at some later time the patient's medication may contain no methadone at all, that the patient has a right to a humane procedure of withdrawal from methadone, and that a procedure for gradual withdrawal is available. The patient shall be advised of the possible adverse effects on him in the event of abrupt methadone withdrawal. (c) Each program shall advise each female patient of child-bearing age that available knowledge on the effects of methadone on pregnant women and their unborn children is inadequate to guarantee that methadone will not produce significant or serious side effects. (d) Each patient shall attest his voluntary participation in a program by signing F.D.A. Form FD 2635, Consent for Methadone Treatment, documenting his knowing consent. After a maintenance treatment patient has been in a program for 30 days or if a patient is readmitted for maintenance treatment after an absence, the program requires that he again read and sign an informed consent form.